Quadrant sees CME potential in Jobson titles

Share this article:
Quadrant HealthCom plans to beef up its med ed offering through four titles recently acquired from Jobson. “The idea is to integrate them into Quadrant and try to give them the kind of support they need to realize their potential,” said Steve Stoneburn, president and CEO of Quadrant. “We’re optimistic we can continue to grow that business.” The acquisitions broaden Quadrant’s audience to 500,000 readers across 13 titles, bolstering the firm’s primary care portfolio and giving it entrée into the neurology, psychiatry pulmonary and NP/PA specialty categories. The titles include Clinician Reviews, Neurology Reviews, Neuropsychiatry Reviews and Pulmonary Reviews. A fifth title included in the deal, Women’s Health in Primary Care, will cease publication, with elements to be added to Quadrant’s The Female Patient. Editor-in-chief Maura Griffith will serve as chief of content development activities at Quadrant Medical Education. Roland DeSilva of DeSilva + Phillips, which brokered the deal for Quadrant, called it “an excellent strategic fit for Quadrant. It rounds out their ability to service the healthcare industry.” Terms of the deal were not disclosed, but revenues for the titles are understood to exceed $10 million.
Share this article:

Email Newsletters

More in News

Star Group merges with Vox Medica, Calcium NYC

Star Group merges with Vox Medica, Calcium NYC

The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.

Survey finds pay doesn't make doctors happy

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed ...